Others have reported that the HDACi trichostatin A increased protein acetylation and trapped PARP1 to double-strand DNA breaks in the K562 leukemia cell line, and the combination of HDACi with talazoparib resulted in a dose-dependent increase in PARP1 trapping, which correlated with apoptosis [34]. This evidence concerns the gene PARP1 and leukemia.